Tissurel®
Breast Reconstruction Post-Mastectomy
Pre-clinicalActive
Key Facts
About 4Tissue
4Tissue is a private, pre-revenue biotech company pioneering a proprietary bioresorbable hydrogel platform for regenerative medicine. Its lead program, Tissurel®, is a first-in-class injectable designed for breast reconstruction that protects and nurtures a patient's own fat or stem cells to generate durable, natural tissue. The company, founded in 2016 by leading academic surgeons and polymer scientists, is addressing a critical unmet need in oncology by aiming to simplify reconstructive surgery and improve patient outcomes with a single, minimally invasive treatment.
View full company profileTherapeutic Areas
Other Breast Reconstruction Post-Mastectomy Drugs
| Drug | Company | Phase |
|---|---|---|
| Melodi Matrix | Melodi Health | Pivotal Trial |